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INTRODUCTION
The introduction of population-based screening programs for colorectal cancer (CRC) has led to a higher incidence of early stage CRCs. 1 Endoscopic resection is an attractive treatment for T1 CRC due to substantially lower morbidity and mortality rates as compared to surgery. 2 Whether endoscopic treatment can be considered curative depends on the risk of incomplete resection and the risk of lymph node metastasis (LNM). An important difference between non-pedunculated and pedunculated T1
CRCs is that pedunculated lesions are especially amenable for endoscopic treatment, since these polyps can be removed relatively easy with en-bloc snare polypectomy with a risk of incomplete resection of less than 3%. 3 The risk of LNM has been reported to be as low as 3-7% in pedunculated T1 CRC, whereas this risk is about 7-14% in non-pedunculated T1 CRC. [4] [5] [6] [7] When doubt exists on the completeness of endoscopic resection, but the risk of LNM is considered to be low, innovative new techniques and devices for endoscopic full-thickness resection may be promising alternatives for major surgery. 8, 9 Nonetheless, lymph node dissection is required when LNM are suspected. To date, no good prediction rule exists to adequately determine the risk for LNM in pedunculated T1 CRC. As a result, up to 46-76% of patients with pedunculated T1 CRC end up having surgery. 4, 7, 10, 11 Up to now, only a limited number of studies have evaluated risk factors for LNM specifically for pedunculated T1 CRC. 4, 5, 7, 12, 13 These studies included only 2 to 10 patients with LNM, and lack longterm follow-up data. Haggitt level 4 invasion, poor differentiation, and lymphovascular invasion have been associated with LNM, and most guidelines therefore recommend considering surgery in the presence of one of these features. [14] [15] [16] As a result, a high proportion of patients are exposed to the risks of surgery without any clinical benefit. Assigning weights to different risk factors might result in a more M A N U S C R I P T
A C C E P T E D ACCEPTED MANUSCRIPT refined risk estimation, allowing individualized predictions that could be of clinical value in the weighted balance between risks and benefits of surgery in patients with pedunculated T1 CRC.
In the present multicenter study, we aimed to develop a prediction model to better estimate the indication for surgery in pedunculated T1 CRC, by reviewing currently used and new histological risk factors on hematoxylin-eosin (H&E) stained slides by expert pathologists. A second aim was to compare the diagnostic performance of our developed model with the currently used decision rules for additional surgery in existing guidelines. [14] [15] [16] 
METHODS

Study design and source population
This was a cohort-nested matched case control study. The study was conducted in the T1 CRC registration cohort, initiated by the Dutch T1 CRC Working Group, a collaboration of Dutch hospitals of which 13 hospitals participated in this study (12 non-academic and 1 academic hospital). All patients with T1 CRC diagnosed between January 1, 2000 and December 31, 2014 in these hospitals were identified using the Netherlands Cancer Registry. The electronic medical records were reviewed.
Exclusion criteria included patients with hereditary predisposition for CRC, inflammatory bowel disease, synchronous advanced CRC (defined as advanced CRC in the previous 5 years before detection of T1 CRC, or elsewhere in the colorectum at the time of detection of T1 CRC), non-CRC related death within one year after treatment, non-adenocarcinoma (e.g. carcinoid), neo-adjuvant radiotherapy, and missing endoscopy or pathology reports. Next, the endoscopy reports were reviewed. All patients with flat or sessile T1 CRCs were additionally excluded, resulting in a cohort of patients with pedunculated T1 CRC (i.e., the endoscopist stated the morphology of the polyp was pedunculated, either by reporting the presence of a stalk or by reporting Paris 0-Ip classification in the endoscopy report). 17 Additional patient and tumor characteristics were collected from the endoscopy, surgery and radiology reports. Follow-up in these patients was performed according to routine clinical care.
This study was approved by the Medical Ethics Review Committee of the University Medical
Center Utrecht (approval for data-collection, reference number: 15-487; approval for histological review, reference number 15-716), and performed in accordance with the Helsinki Declaration. The study conforms to the TRIPOD statement for studies developing a prediction model.
Outcome definition
The study aim was to better estimate the indication for surgery. We used a composite endpoint for this, in which pedunculated T1 CRCs with either LNM, intramural or distant metastasis were identified as cases. Pedunculated T1 CRCs with LNM have an indication for surgery assuming that an adequate lymph node dissection prevents further spread. Pedunculated T1 CRCs that develop an intramural or distant metastasis have an indication for surgery assuming that these might have resulted from missed LNM, either because no surgery or an inadequate lymphadenectomy was performed. LNM was defined as ≥1 positive lymph node(s) in the resection specimen as reported in the pathology report. Intramural metastasis was defined as malignant tissue at the site of the anastomosis after surgery, or at the polypectomy site after endoscopic resection only when margins were free of cancer tissue. This was defined as such, because in the latter situation tumor remains, even though the tumor free margins of the polypectomy specimen suggested completeness of resection, and thus polypectomy alone was insufficient in these cases. Distant metastasis was defined as metastasis to extra-colonic organs, bone or peritoneum as confirmed with imaging or histology. For the readability, we use the term 'metastasis'
for this composite endpoint throughout this paper.
Control selection
Pedunculated T1 CRC patients without metastasis were matched as controls for the cases on a 3:1 ratio (Supplementary Figure S1 ). Controls were matched (without replacement) by treatment method (primary endoscopic resection vs secondary surgical resection vs primary surgical resection) and tumor location (colon vs rectum or rectosigmoid), while using incidence density sampling (i.e., controls were selected from all those patients who have accrued at least the same length of follow-up as the duration of case occurrence). 19 For patients only treated with endoscopic resection, controls were additionally matched by R0-resection margins, as all cases were also R0-resections (i.e., to prevent selection bias).
The researchers that performed the matching procedure (YB, LMGM) were blinded for the original histological reports and not involved in the histological review process.
Pathology review and histological factors
Candidate histological factors for review included histological factors evaluated in previous pedunculated T1 CRC studies as well as new promising factors only evaluated in non-pedunculated T1 4, 5, 7, 10, 12, 13, [20] [21] [22] [23] [24] [25] [26] Selected factors were differentiation grade, submucosal invasion depth according to the Haggitt classification, lymphovascular invasion, tumor budding, poorly differentiated clusters (PDC) and the condition of the muscularis mucosae (MM). A quantitative evaluation of invasion depth and invasion width were not included, since proper assessment of these factors is highly dependent on specimen handling (e.g., adequate transverse sections). 5, 10 The definitions, methods of assessment and grading of the histological factors are presented in Supplementary Table S1 . If the Haggitt classification could not be determined (e.g. due to piecemeal resection), this factor was considered absent.
The H&E stained slides of the selected cases and controls were collected from the participating hospitals. The median number of slides per polyp was 5 (IQR 2 -8); all polyps were totally embedded.
Slice thickness varied between 3 and 4 µm (information obtained from the pathology reports and participating centers). Two pathologists with special expertise in gastrointestinal pathology (MML & GJAO) reviewed the H&E slides, both blinded for the clinical characteristics and the original histological report. The slides were mutually reviewed to confirm the diagnosis T1 CRC, and excluded if the diagnosis could not be confirmed. T1 CRC was defined as invasion through the muscularis mucosae and into, but not beyond, the submucosa. 27 To optimize the reproducibility of histologic assessment, the first 30 cases (randomly selected) were also mutually reviewed on the candidate predictors. Consensus was reached on the interpretation of the definitions of the new parameters (i.e., status of the muscularis mucosa, PDC and tumor budding). After this set, the pathologists felt confident that a single pathologic evaluation would suffice as long as low confident cases would be discussed. Therefore, histological factors in the remaining set were reviewed by MML, and discussed with GJAO in case of uncertainty. To test the reproducibility, two pathologists (MGR and PD) from two high volume community hospitals were invited to review another set of 30 randomly selected cases in which the inter observer agreement with the study pathologist's assessment (i.e, assessment by MML which was optionally discussed with GJAO) was estimated (see Supplementary Methods). 28 
Statistical analysis
All analyses were performed using IBM SPSS Statistics version 21 (SPSS Inc., Chicago, IL, USA), In view of the small number of patients in some histological factor categories, we binned some of these variables before further analysis, based on previous literature and current guidelines (Supplementary 29 This is a logistic regression model that penalizes the absolute size of the coefficients of a regression model, based on the value of lambda. With larger penalties, the estimates of weaker factors shrink towards zero, so that only the strongest predictors remain in the model. Details regarding all steps performed can be found in the Supplementary Methods. We took into account the sampling fraction of controls for each matching factor thus extrapolating the findings developed in the nested case-control set to the entire cohort. We reported the resulting prediction rule enabling the calculation of the predicted probability of the outcome in new patients, the apparent and cross-validated area under the curve (AUC), calibration plots, and accuracy measures (i.e. sensitivity, specificity, negative and positive predictive value (NPV/PPV)) according to different predicted probability thresholds defining high-risk T1 CRC (and thus surgical referral).
During the above described multivariable modeling, we observed an unanticipated negative association between tumor budding and metastasis. As tumor budding and PDC are closely related phenomena which may have contributed to this unexpected observation, we additionally analyzed our data by combining PDC and budding as one variable (positive in the presence of either tumor budding grade 2-3 or PDC grade 2-3 and negative otherwise), similar to previous studies. [30] [31] [32] [33] We therefore
report on two models: LASSO model 1 that considers PDC and budding separately, and LASSO model 2 that combines these entities.
Comparison with conventional models
The diagnostic performance of the decision rules in existing guidelines was calculated, defined as 'conventional models', in order to compare it with our LASSO-derived models. [14] [15] [16] In conventional model 1, high-risk T1 CRC was defined as T1 CRC with either poor differentiation, lymphovascular invasion, or
Haggitt level 4, according to the European Society for Medical Oncology (ESMO) and the American Society for Gastrointestinal Endoscopy (ASGE). 14, 15 In conventional model 2, high-risk T1 CRC was defined as T1 CRC with either poor differentiation, lymphovascular invasion, Haggitt level 4, or tumor budding, since budding has been implemented as indicator for additional surgery in the Japanese Society for Cancer of the Colon and Rectum (JSCCR guidelines). 16 In the absence of all these features it was considered a low-risk T1 CRC. Receiver operating characteristics (ROC)-curves were plotted for all models, and curves were compared using the DeLongs test. Sensitivity and specificity were compared with the McNemar test. After adjustment for the sampling fraction (in the same manner as described above), absolute outcome probabilities were calculated.
RESULTS
Study population
In total, 2253 patients with T1 CRC were identified in the Netherlands Cancer Registry. Among these, 708 eligible patients with pedunculated T1 CRCs were selected. A study flowchart and baseline characteristics of the source population can be found in Supplementary Material Figure S1 and Figure S1 ). Baseline characteristics of cases and controls are presented in Table 1 
Histological factors in cases vs controls
The presence of histological factors in cases vs. controls is shown in Table 2 .
Model development
Using multivariable LASSO regression, we identified a total of 5 out of 6 histological factors that The regression coefficients, LASSO-derived multivariate ORs, and the intercept of both LASSO models are presented in Table 3 . The plots of the cross-validation AUC according to the penalty and the coefficient profile plots can be found in the Supplementary Material ( Figure S2-S3 ). Both models showed good calibration (Supplementary Figure S4 ).
As an illustration, we depicted a score chart with the estimated predicted probability for metastasis using LASSO model 2 ( Table 4 ). For example, a pedunculated T1 CRC with MM type A,
Haggitt level 4 invasion, no lymphovascular invasion and no budding (PDC or tumor budding) had an estimated 1.4% risk for metastasis, whereas this risk increased to 5.0% in the presence of lymphovascular invasion.
Model performance and comparison with conventional models
We next evaluated the diagnostic performance of the LASSO models. In our data, LASSO model 1 (i.e., Sensitivity and specificity of the models were calculated ( Figure 2 Figure 2 ).
Clinical implications in entire cohort
To provide more insight in the clinical implications, we translated the findings in the development (nested-matched) set to the entire cohort of 708 pedunculated T1 CRCs. The number of patients tested positive (i.e., high-risk T1 CRC), the number of patients inappropriately not referred for surgery (i.e., missed cases), and the number of high-risk patients in whom metastases were observed (i.e., PPV) are 
Inter observer agreement
Two pathologists were invited to test the inter observer agreement in a random sample of 30 cases
( Supplementary Table S4 ). Using LASSO model 1 at a 4% threshold, they agreed with the study pathologist's assessment in 87% and 97% of cases with a kappa of 0.73 (substantial) and 0.93 (almost perfect) for pathologist 1 and 2, respectively. For LASSO 2, agreement was observed in 73% and 87%
with a kappa of 0.48 (moderate) and 0.68 (substantial) for pathologist 1 and 2, respectively.
DISCUSSION
Clinicians encounter T1 CRCs with increasing frequency and are faced with the difficulty of selecting candidates who will benefit from surgery in an increasing proportion of CRC patients. 1 To date, a simplified risk stratification is used that divides patients into low-and high-risk groups based on histological risk factors. 14, 15 Although it is known that some histological factors (e.g. lymphovascular invasion) are stronger and more robustly associated with metastasis than others (e.g. poor differentiation), conventional risk models do not take this into account. [14] [15] [16] Moreover, conventional models do not stratify based on polyp morphology, whereas the risk of LNM is much lower in pedunculated than non-pedunculated T1 CRC. [4] [5] [6] [7] The two major steps forward of our strategy is that histological risk factors were weighted and compiled into a final estimate, and that this was done specifically for pedunculated T1 CRC. We incorporated both currently used and novel promising to weigh this risk against the risk for surgical morbidity and mortality.
Our model was developed using a large Dutch multicenter cohort. Previous prediction models have shown that estimates of the model's performance can be influenced in several ways when assessed in a new population. 18 The regression coefficients can be incorrect, often seen as a result of statistical overfitting. We however performed several steps to minimize this risk (i.e., internal validation using cross-validation and shrinkage of coefficients at model development). Moreover, the model's performance also depends on the case-mix to which the model is applied. In our cohort, the background risk of metastasis in pedunculated T1 CRC was 5.2%, which is comparable to incidence rates of metastasis in pedunculated T1 CRC reported in cohorts outside the Netherlands (all Asian cohorts).
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To further enhance the reproducibility of our model, we evaluated all histological factors according to previously described (consensus) definitions. Moreover, the calculation of our model does not need sophisticated assessment strategies, as all risk factors can be evaluated on H&E stained slides readily available in laboratories throughout the world. Furthermore, the observation that the inter observer agreement was reasonably good supports that our model can be applied by other pathologists.
We used a cohort-nested matched case control design and composite endpoint, which is an efficient approach to study associations when the outcome is rare. A composite endpoint of LNM, intramural and distant metastasis was used rather than LNM alone as endpoint for two reasons. First, it increased the robustness of our analysis. Although the present T1 CRC cohort is one of the largest to date, only 23 eligible pedunculated T1 CRC patients with LNM could be identified. Second, it enabled us to identify pedunculated T1 CRCs with high vs. low metastatic potential. The presence of LNM is one of the strongest prognostic factors in CRC. 34 The concept of a sequential progression of tumor cells, in which LNM are precursors of distant metastases, forms the basis of the TNM staging system. 34 In this way, lymph node dissection, which is the primary reason to proceed to surgery in T1 CRC, prevents seeding of distant metastasis. An alternative model is that distant metastases arise independently of LNM, supported by a recent study that observed genetically distinct origins of LNM and distant metastasis, indicating that both types of metastatic lesions likely originate from distinct sub clones in the primary tumor. 35 In this view, using a composite endpoint to identify biologically aggressive pedunculated T1 CRCs in which endoscopic resection alone is insufficient seems more appropriate. To explore the magnitude of potential bias introduced by using a composite endpoint, we compared Table S3 ).
Ideally, the model would not miss any patients with metastasis. Our study shows that in all scenarios, irrespective whether conventional or our models are used, patients with metastasis will be missed, unless the threshold is set at a value with a very low specificity. However, even after surgery there is still a 0.3-4.5% risk that patients with T1 CRC develop metastasis. 2, 36 Surgery therefore decreases the risk of metastasis, but is not a curative treatment for each patient. Our model is the first that enables the calculation of the individual T1 CRC patient's risk for metastasis, facilitating to weigh this risk against the risk of surgical mortality based on the patient's profile (age, condition and comorbidity). 37, 38 For example, a patient <75 years old with ASA-score I, has an estimated surgical mortality and morbidity risk of 0.1 -1.0% and 20 -24% respectively, vs. 7.5 -9.4% and 36 -37% respectively for a patient ≥75 years with an ASA-score III-IV. As a consequence, the threshold for surgical referral when using our model for these patients needs to be adjusted. 37, 38 In our study, tumor budding was associated with metastasis in univariate analysis (OR 1.9), however, this positive association was no longer present in multivariate analysis. Although unanticipated, previous work of Ueno et al., conducted in stage II-III CRCs, also showed a univariate association between tumor budding and metastasis (HR 4.6) which disappeared when correcting for PDC. 22 The authors' explanation was the difficulty to assess tumor budding on H&E-stained slides, necessitating immuno-histochemical staining for accurate identification of single cancer cells and small cell clusters. We also experienced this difficulty, and especially the quantification of the number of cells per undifferentiated cluster was problematic. The observation of Ueno et al. that the intra-observer reproducibility for PDC was much better than for tumor budding further supports this notion. 22 In addition, Barresi et al. evaluated both tumor budding and PDC in 101 T1 CRC specimens, and observed no association between tumor budding and metastasis, whereas PDC appeared to be a strong independent factor. 39 Both PDC and tumor budding are associated with epithelial-mesenchymal transition, an important process in the initiation of metastasis. 40 It therefore seems rather arbitrary to use a cut-off of 5 cells per cluster to define whether it is called tumor budding or PDC. Interpreting these factors as one phenomenon, as done in LASSO model 2, therefore seems logical from a biological perspective. 22, 39 A validation study should confirm whether interpreting these factors as one entity indeed results in comparable accuracy, as we observed.
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Both the qualitative (i.e., sm1 vs sm2-3) and quantitative (i.e., ≥1000 µm) evaluation of invasion depth have been associated with LNM in sessile T1 CRCs. 20 Quantitative assessment of invasion depth is however much more complicated in pedunculated T1 CRC (e.g. due to differences in the length of stalks). An additional disadvantage is that its assessment is highly dependent on tissue handling and processing. Although we therefore decided not to incorporate this parameter as candidate predictor in our model, we did find it interesting to explore its value in pedunculated T1 CRC. . This is in line with previous studies that quantitatively evaluated invasion depth in pedunculated T1 CRC, and limits the chance that this factor would have contributed to the diagnostic accuracy of our model. 5, 13 Instead, we evaluated the Haggitt classification, and confirmed previous studies that this factor per se is insufficient for risk stratification. 7, 13, 41 For an adequate assessment, it is essential that both the endoscopist and pathologist handle the polyp in such a way that accurate information concerning the level of invasion can be obtained, as underlined by Haggitt et al. 12 If malignancy is suspected, the stalk should be snared at the base, so that the pathologist can distinguish
Haggitt 3 from Haggitt 4 invasion.
We observed that the risk for metastasis was very low in pedunculated T1 CRC with MM type A. This is in line with four previous studies, which observed a metastasis risk of 0% (0/44), 0% (0/18), 0%
(0/43) and 2.4% (1/41) when the MM was preserved. 21, 25, 42, 43 Taken these and our study together, the proposed strategy of Miyachi et al to be very conservative with the decision to perform additional surgery when the MM is intact seems justified. 25 Our study flowchart depicts that approximately 42% of T1 CRCs were pedunculated, comparable to previous studies reporting proportions between 40-60%. 11, 44 A relative high proportion of patients was excluded due to missing reports or early death, however, evaluation of characteristics of these patients does not suggest major concerns regarding selection bias (data not shown). Study characteristics of the source population were also comparable to previous pedunculated T1 CRC studies. 4, 5, 7, 13 We extrapolated the findings developed in the nested case-control set to the entire cohort by updating the intercept so that the average predicted probabilities of the model corresponded with the average risk for metastasis in the source population, i.e. pedunculated T1 CRC. It should M A N U S C R I P T
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however be noted that this prevalence remains an estimate. Pathologists experience diagnostic difficulty distinguishing pseudo-invasion and high-grade dysplasia from T1 CRC, which might have resulted in an underestimation of the metastasis risk. 45 It is however very difficult to account for this, since diagnosis of T1 CRC in pedunculated lesions is a contemporary challenge even for expert pathologists, and a golden standard does not exist. 45, 46 The incidence of 5.2% used for our analysis seems justified, since there were also cases revised as T2 CRC, and this is in good agreement with previous reported incidence rates varying between 3 -7%. tumor localization -and perhaps other factors as well -in future studies to attempt to further improve and refine risk stratification in these patients.
Our study has some limitations. Most important, despite that our cohort is the largest pedunculated T1 CRC cohort to date, the absolute number of patients with metastasis was still low. For this reason, we used all cases for the development of the model, and used cross-validation for interval validation, together with a statistical analysis approach specifically useful to allow robust multivariable prediction modeling in small datasets. However, before considering implementation of our model in general practice, the model needs to be formally validated in another cohort, preferably prospectively but at least in another independent set of archival slides. This formal validation will possibly also clarify which of the two LASSO models is most suitable for risk stratification. A second limitation is that we M A N U S C R I P T
17 used archival slides, resulting that tissue processing was not standardized. This might however also enhance generalization of our results. Slice thickness and orientation vary throughout the world, and our cohort hereby reflects real time practice. Importantly, most of the parameters incorporated in our model could be assessed even when the specimen was fragmented or inadequately handled. Moreover, although tissue handling was not standardized, the pathologic assessment itself was fully standardized.
Established definitions were used, and only H&E stained slides were evaluated (including in the cases in which additional stainings were available) to prevent variability in assessment introduced by the availability of additional stainings. Nevertheless, although the inter observer agreement was reasonably good, it should be noted that histological assessment will always be subject to inter observer variation.
Finally, although baseline characteristics were comparable, we cannot exclude that -as in any casecontrol study -there are differences between the groups that were not accounted for. Moreover, the number of LNs retrieved during surgery was relatively low. 14 As low LN yield has been associated with increased risk for recurrence, this might have resulted in an underestimated incidence of metastasis.
The number of retrieved LNs was however equally distributed over cases and controls and the estimated risk for metastasis did not significantly differ between patients with low (<12) and high (≥12) LN yield (data not shown), making it less likely that this has caused a significant bias.
In conclusion, current guidelines (ESMO, ASGE, JSCCR) provide a weak recommendation to consider surgery in patients with pedunculated T1 CRC in the presence of one of the histological highrisk factors, resulting in a high proportion of patients referred for surgery without any benefit. This multicenter study is not only the first to evaluate the diagnostic performance of the decision rules in existing guidelines in a large multicenter cohort, but is also the first to evaluate an alternative strategy.
We propose two models with a significantly better specificity while maintaining comparable sensitivity, thus having the potential to safely reduce unnecessary surgery substantially. Table 5 . Note: For ease of use the table has been colour coded. It displays a green (low risk for metastasis) to red (high risk for metastasis) gradient, with the shade of the colour representing the value in the cell.
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Supplementary Methods
Model development
We evaluated the association between the histological factors and the outcome with uni-and multivariable conditional logistic regression analyses, acknowledging the matched design. In view of our limited number of metastasis in relation to the number of potential histological predictors, we conducted a penalized analysis for the development of the prediction model, named L1 penalized least absolute shrinkage and selection (LASSO) logistic regression, augmented with 5-fold crossvalidation for internal validation. This is a logistic regression model that penalizes the absolute size of the coefficients of a regression model, based on the value of lambda (λ). With larger penalties, the estimates of weaker factors shrink towards zero, so that only the strongest predictors remain in the model. We identified the optimal λ penalty under five-fold cross-validation, maximizing the crossvalidation area under the receiver operating characteristic curve (AUC). Matched cases and controls were kept together. We then refitted a penalized model with that λ penalty on the full data, resulting in a final set of regression coefficients (i.e. log(ORs)) for the histological factors). As a final step, we updated the intercept of that model so that the average predicted probabilities of the model corresponded with the average risk for metastasis, by taking into account the sampling fraction of controls for each matching factor thus extrapolating the findings developed in the nested case-control cohort to the entire cohort.
Inter observer agreement
To test whether application of the LASSO models was reproducible, we invited two pathologists (MGR and PD) from two high volume community hospitals to review a set of 30 randomly selected cases.
The correlation between the estimated risk for metastasis of the study pathologist's assessment (i.e., the assessment by expert pathologist MML, which was discussed with expert pathologist GJAO in case of uncertainty) vs the two external pathologists when using the LASSO models was calculated with use of the intraclass correlation (ICC). We additionally calculated the agreement between the pathologists when using an estimated metastasis risk ≥4% as threshold for surgical referral with
Cohen's kappa (between two pathologists) and Fleiss kappa (between three pathologists). 
Agreements
